TLOG (TetraLogic Pharmaceuticals) Total Equity: $-30.94 Mil (As of Sep. 2016)


What is TetraLogic Pharmaceuticals Total Equity?

TetraLogic Pharmaceuticals TLOG Total Equity is $-30.94 Mil as of Sep. 2016.

TetraLogic Pharmaceuticals's total equity for the quarter that ended in Sep. 2016 was $-30.94 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

TetraLogic Pharmaceuticals Total Equity Historical Data

* Premium members only.

The historical data trend for TetraLogic Pharmaceuticals's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TetraLogic Pharmaceuticals Total Equity Chart

TetraLogic Pharmaceuticals Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15
Total Equity
-52.59 -68.44 50.55 33.40 -5.94

TetraLogic Pharmaceuticals Quarterly Data
Dec11 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 -5.94 -16.06 -22.26 -30.94

TetraLogic Pharmaceuticals Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

TetraLogic Pharmaceuticals's Total Equity for the fiscal year that ended in Dec. 2015 is calculated as

Total Equity=Total Assets(Q: Dec. 2015 )-Total Liabilities(Q: Dec. 2015 )
=64.021-69.962
=-5.94

TetraLogic Pharmaceuticals's Total Equity for the quarter that ended in Sep. 2016 is calculated as

Total Equity=Total Assets(Q: Sep. 2016 )-Total Liabilities(Q: Sep. 2016 )
=42.788-73.726
=-30.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of $-30.94 Mil mean?
TetraLogic Pharmaceuticals (TLOG) has a Total Equity of $-30.94 Mil as of Sep. 2016. The total amount of equity as record on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors.
Is TetraLogic Pharmaceuticals' Total Equity too high?
TetraLogic Pharmaceuticals' current Total Equity is $-30.94 Mil.
How does TetraLogic Pharmaceuticals' Total Equity compare to ARGSQ and GTHR?
TetraLogic Pharmaceuticals' Total Equity of $-30.94 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Biotechnology company?
A good Total Equity depends on the Biotechnology industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for TetraLogic Pharmaceuticals and its competitors. TetraLogic Pharmaceuticals's current Total Equity is $-30.94 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TetraLogic Pharmaceuticals stock overvalued right now?
TetraLogic Pharmaceuticals (TLOG) has a current Total Equity of $-30.94 Mil. The current Total Equity is $-30.94 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For TetraLogic Pharmaceuticals (TLOG), the current Total Equity is $-30.94 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TetraLogic Pharmaceuticals Business Description

Address 343 Phoenixville Pike, Malvern, PA, USA, 19355
TetraLogic Pharmaceuticals Corp is a biopharmaceutical company. The company is engaged in developing novel small molecule therapeutics in oncology.